Health Catalyst Inc (NASDAQ: HCAT) kicked off on Friday, down -9.47% from the previous trading day, before settling in for the closing price of $8.45. Over the past 52 weeks, HCAT has traded in a range of $5.42-$11.41.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 21.79%. While this was happening, its average annual earnings per share was recorded 111.68%. With a float of $58.33 million, this company’s outstanding shares have now reached $60.85 million.
The extent of productivity of a business whose workforce counts for 1300 workers is very important to gauge. In terms of profitability, gross margin is 35.68%, operating margin of -21.37%, and the pretax margin is -26.25%.
Health Catalyst Inc (HCAT) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Health Information Services Industry. The insider ownership of Health Catalyst Inc is 4.14%, while institutional ownership is 87.33%. The most recent insider transaction that took place on Nov 15 ’24, was worth 11,534. Before that another transaction happened on Nov 05 ’24, when Company’s Chief Operating Officer sold 5,209 for $7.70, making the entire transaction worth $40,127. This insider now owns 129,690 shares in total.
Health Catalyst Inc (HCAT) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 111.68% per share during the next fiscal year.
Health Catalyst Inc (NASDAQ: HCAT) Trading Performance Indicators
Take a look at Health Catalyst Inc’s (HCAT) current performance indicators. Last quarter, stock had a quick ratio of 1.41. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.35, a number that is poised to hit 0.08 in the next quarter and is forecasted to reach 0.40 in one year’s time.
Technical Analysis of Health Catalyst Inc (HCAT)
The latest stats from [Health Catalyst Inc, HCAT] show that its last 5-days average volume of 0.55 million was inferior to 0.56 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 51.74%. Additionally, its Average True Range was 0.56.
During the past 100 days, Health Catalyst Inc’s (HCAT) raw stochastic average was set at 60.43%, which indicates a significant increase from 14.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 74.38% in the past 14 days, which was lower than the 79.69% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.16, while its 200-day Moving Average is $7.40. Now, the first resistance to watch is $8.28. This is followed by the second major resistance level at $8.92. The third major resistance level sits at $9.24. If the price goes on to break the first support level at $7.32, it is likely to go to the next support level at $7.00. The third support level lies at $6.36 if the price breaches the second support level.
Health Catalyst Inc (NASDAQ: HCAT) Key Stats
The company with the Market Capitalisation of 421.41 million has total of 60,848K Shares Outstanding. Its annual sales at the moment are 295,940 K in contrast with the sum of -118,150 K annual income. Company’s last quarter sales were recorded 76,350 K and last quarter income was -14,730 K.
